Related Experiment Video
Updated: Sep 9, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Diweng Zhixie Power Ameliorates Dampness-Heat Diarrhea by Restoring Intestinal Microbiota Dysbiosis and Short-Chain
Xia Song1, Wen-Wen Mi1, Hao Zhang1
1College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, Gansu Province, People's Republic of China.
Abstract:
Current therapeutics for diarrhea have limitations. Classical Formula Diweng Zhixie power (DW) is derived from Shang Han Lun and has a long history of treating gastrointestinal diseases such as diarrhea. Nevertheless, the exact mechanism of it needs to be further clarified. We aimed to investigate the treatment effect of DW on dampness-heat diarrhea in rats. HPLC quantified the bioactive components. Rats were assessed for weight, temperature, water intake, and diarrhea severity. Inflammation markers and protein pathways were analyzed via ELISA and Western blot. GC-MS measured cecal SCFAs, while 16S rRNA sequencing evaluated gut microbiota. The contents of esculin, jatrorrhizine, palmatine, berberine, esculetin, gallic acid, catechin, and anemoside B4 in DW were 0.134%, 0.165%, 0.046%, 0.30%, 0.099%, 0.309%, 0.312%, and 0.870%, respectively. DW alleviated dampness-heat diarrhea in rats and restored the intestinal microbiota dysbiosis. Furthermore, DW efficiently suppressed the abnormal inflammatory response and reduced the severity of pathological damage, restored the level of inflammatory factors, increased the expression of G-coupled protein and the content of SCFAs in the model group. The mechanisms by which DW protects against dampness-heat diarrhea may involve restoring goblet cell function, repairing intestinal microbiota dysbiosis, and modulating the inflammatory response, with GPCRs acting a critical role in the antidiarrhea effect of DW.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

